Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2023 | 6 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study.
Expert Opin Ther Targets. 2023 Jul-Dec;27(12):1177-1188. doi: 10.1080/14728222.2023.2288277. Epub 2023 Dec 30.
Expert Opin Ther Targets. 2023.
PMID: 37997756
Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair.
Wang M, Li W, Tomimatsu N, Yu CH, Ji JH, Alejo S, Witus SR, Alimbetov D, Fitzgerald O, Wu B, Wang Q, Huang Y, Gan Y, Dong F, Kwon Y, Sareddy GR, Curiel TJ, Habib AA, Hromas R, Dos Santos Passos C, Yao T, Ivanov DN, Brzovic PS, Burma S, Klevit RE, Zhao W.
Wang M, et al.
Mol Cell. 2023 Oct 19;83(20):3679-3691.e8. doi: 10.1016/j.molcel.2023.09.015. Epub 2023 Oct 4.
Mol Cell. 2023.
PMID: 37797621
Item in Clipboard
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.
Venkata PP, Jayamohan S, He Y, Alejo S, Johnson JD, Palacios BE, Pratap UP, Chen Y, Liu Z, Zou Y, Lai Z, Suzuki T, Viswanadhapalli S, Weintraub ST, Palakurthi S, Valente PT, Tekmal RR, Kost ER, Vadlamudi RK, Sareddy GR.
Venkata PP, et al.
Cancer Lett. 2023 Oct 28;575:216383. doi: 10.1016/j.canlet.2023.216383. Epub 2023 Sep 14.
Cancer Lett. 2023.
PMID: 37714256
Item in Clipboard
Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma.
Pratap UP, Tidwell M, Balinda HU, Clanton NA, Yang X, Viswanadhapalli S, Sareddy GR, Liang D, Xie H, Chen Y, Lai Z, Tekmal RR, McHardy SF, Brenner AJ, Vadlamudi RK.
Pratap UP, et al.
Mol Cancer Ther. 2023 Nov 1;22(11):1248-1260. doi: 10.1158/1535-7163.MCT-23-0031.
Mol Cancer Ther. 2023.
PMID: 37493258
Free PMC article.
Item in Clipboard
Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression.
He Y, Alejo S, Johnson JD, Jayamohan S, Sareddy GR.
He Y, et al.
Cancers (Basel). 2023 Mar 28;15(7):2008. doi: 10.3390/cancers15072008.
Cancers (Basel). 2023.
PMID: 37046668
Free PMC article.
Item in Clipboard
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma.
Alejo S, Palacios BE, Venkata PP, He Y, Li W, Johnson JD, Chen Y, Jayamohan S, Pratap UP, Clarke K, Zou Y, Lv Y, Weldon K, Viswanadhapalli S, Lai Z, Ye Z, Chen Y, Gilbert AR, Suzuki T, Tekmal RR, Zhao W, Zheng S, Vadlamudi RK, Brenner AJ, Sareddy GR.
Alejo S, et al.
Neuro Oncol. 2023 Jul 6;25(7):1249-1261. doi: 10.1093/neuonc/noad018.
Neuro Oncol. 2023.
PMID: 36652263
Free PMC article.
Item in Clipboard
PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.
Luo Y, Li M, Pratap UP, Viswanadhapalli S, Liu J, Venkata PP, Altwegg KA, Palacios BE, Li X, Chen Y, Rao MK, Brenner AJ, Sareddy GR, Vadlamudi RK.
Luo Y, et al.
Mol Carcinog. 2020 Mar;59(3):281-292. doi: 10.1002/mc.23152. Epub 2019 Dec 24.
Mol Carcinog. 2020.
PMID: 31872914
Free PMC article.
Item in Clipboard
Cite
Cite